Dianthus Therapeutics, Inc. (DNTH)
79.22
+1.22
(+1.56%)
USD |
NASDAQ |
Mar 17, 14:05
Dianthus Therapeutics EPS Diluted (Quarterly) : -1.433 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Daré Bioscience, Inc. | -0.2793 |
| Relmada Therapeutics, Inc. | -0.304 |
| Ocugen, Inc. | -0.0567 |
| Cartesian Therapeutics, Inc. | -3.559 |
| Stoke Therapeutics, Inc. | -0.6543 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -64.43M |
| Revenue (Quarterly) | 0.284M |
| Total Expenses (Quarterly) | 64.72M |
| Enterprise Value | 2.968B |
| Gross Profit Margin (Quarterly) | 65.85% |
| Profit Margin (Quarterly) | -22.69K% |
| Earnings Yield | -5.19% |
| Normalized Earnings Yield | -5.192 |